Summary of clinical results
DUCRAY
Tolerance and efficacy of KERACNYL GLYCOLIC+ unclogging cream in monotherapy
Tolerance and efficacy of KERACNYL GLYCOLIC+ unclogging cream in monotherapy in subjects with mild to moderate acne, under dermatological and ophthalmological control
Population
50 pre-adolescent, adolescent and adult subjects (9 to 35 years old) with mild to moderate non-inflammatory acne on the face associated with hyperseborrhea
Application of KERACNYL GLYCOLIC+ unclogging cream
Application twice a day (morning/evening) to the entire face for 8 weeks
Evaluation criteria
- Clinical scoring of efficacy on acne lesions: Lucky Method acne lesion count
- Quantification of seborrhea (sebum meter)
- Efficacy perceived by the subject
- Skin and eye tolerance
Results
- From 7 days, significant decrease in the number of non-inflammatory lesions
- At 7 days, highly significant decrease in the quantity of sebum of -45% (p<0.001)
- At 1 month, significant decrease in the surface area of post-inflammatory hyperpigmentation lesions of -52%
- Very good skin tolerance and excellent eye tolerance
Conclusion
- Efficacy on non-inflammatory lesions from 7 days
- Anti-seborrheic action
- Very good tolerance
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.